研究者業績

楯谷 一郎

タテヤ イチロウ  (Ichiro Tateya)

基本情報

所属
藤田医科大学 耳鼻咽喉科・頭頸部外科 主任教授
学位
医学博士(2003年3月 京都大学)

J-GLOBAL ID
201401077159748457
researchmap会員ID
7000008738

1994年 京都大学医学部卒業

1994年 京都大学医学部附属病院 研修医

1995年 滋賀県立成人病センター 耳鼻咽喉科 医員

1998年 京都大学医学部附属病院 耳鼻咽喉科 医員

2003年 京都大学大学院医学研究科修了 博士(医学)

2003年 ウィスコンシン大学 耳鼻咽喉科・頭頸部外科 研究員

2006年 京都桂病院 耳鼻咽喉科 医長

2008年 京都大学医学部附属病院 耳鼻咽喉科・頭頸部外科 助教

2013年 京都大学大学院医学研究科 耳鼻咽喉科・頭頸部外科 講師

2019年 京都大学大学院医学研究科 耳鼻咽喉科・頭頸部外科 准教授

2019年 藤田医科大学医学部 耳鼻咽喉科・頭頸部外科 主任教授(現職)

2021年 藤田医科大学病院 頭頸部・甲状腺内視鏡手術センター長(併任)


論文

 296
  • 天野 実貴子, 楯谷 一郎, 加藤 久幸, 吉岡 哲志, 岩田 義弘, 田邉 陽介
    小児耳鼻咽喉科 45(Suppl.) 104-104 2024年6月  
  • 八木 智佳子, 加藤 久幸, 九鬼 伴樹, 吉岡 哲志, 楯谷 一郎
    耳鼻咽喉科臨床 補冊 (補冊166) 150-150 2024年6月  
  • 佐野 大佑, 上田 勉, 堀 龍介, 丸尾 貴志, 森 照茂, 楯谷 一郎, 塚原 清彰, 折舘 伸彦
    日本気管食道科学会会報 75(2) 126-126 2024年4月  
  • 八木 智佳子, 森 茂彰, 岩田 義弘, 吉岡 哲志, 加藤 久幸, 楯谷 一郎
    日本気管食道科学会会報 75(2) s53-s53 2024年4月  
  • 天野 実貴子, 加藤 久幸, 楯谷 一郎, 吉岡 哲志, 岩田 義弘, 九鬼 伴樹
    日本耳鼻咽喉科頭頸部外科学会会報 127(4) 608-608 2024年4月  
  • 吉岡 哲志, 浅井 康徳, 加藤 久幸, 岡野 高之, 池田 裕隆, 楯谷 一郎
    日本耳鼻咽喉科頭頸部外科学会会報 127(4) 617-617 2024年4月  
  • Jun Muto, Ichiro Tateya, Hirofumi Nakatomi, Ichiro Uyama, Yuichi Hirose
    Neurospine 21(1) 106-115 2024年3月31日  
    Objective: The application of the da Vinci Surgical System in neurosurgery is limited due to technical difficulties requiring precise maneuvers and small instruments. This study details the advantages and disadvantages of robotics in neurosurgery and the reachable range of the transoral approach to lesions of the skull base and upper cervical spine.Methods: In a cadaver study, the da Vinci Xi robot, lacking haptic feedback, was utilized for sagittal and coronal approaches on 5 heads, facilitating dura suturing in 3, with a 30°-angled drill for bone removal.Results: Perfect exposure of all the nasopharyngeal sites, clivus, sellar, and choana, including the bilateral eustachian tubes, was achieved without any external incisions using this palatal split approach of transoral robotic surgery. The time required to perform a single stitch, knot, and complete single suture in robotic suturing of deep-seated were significantly less compared to manual suturing via the endonasal approach.Conclusion: This is the first report to show the feasibility of suturing the dural defect in deep-seated lesions transorally and revealed that the limit of reach in the coronal plane via a transoral approach with incision of the soft palate is the foramen ovale. This preclinical investigation also showed that the transoral robotic approach is feasible for lesions extending from the sellar to the C2 in the sagittal plane. Refinement of robotic instruments for specific anatomic sites and future neurosurgical studies are needed to further demonstrate the feasibility and effectiveness of this system in treating benign and malignant skull base lesions.
  • Daisuke Sano, Ichiro Tateya, Ryusuke Hori, Tsutomu Ueda, Terushige Mori, Takashi Maruo, Kiyoaki Tsukahara, Nobuhiko Oridate
    Japanese journal of clinical oncology 2023年12月7日  
    Transoral robotic surgery (TORS), introduced by Weinstein et al. in 2005, has been widely adopted as a minimally invasive procedure, particularly for the treatment of patients with early stage oropharyngeal cancer. TORS is typically performed using the da Vinci Surgical System, similar to robot-assisted surgeries for other malignancies. The main difference between TORS and these other robot-assisted surgeries is that it is performed through the natural orifice of the mouth, which limits the surgical working space, and that it progresses from the lumen of the pharynx to the deeper tissues. The advantages of TORS are mainly due to the benefits of using the da Vinci Surgical System, such as three-dimensional high-definition images, magnification, multiple forceps articulation, tremor-stabilization function and motion scale function. To date, many big data and meta-analyses have shown that TORS is superior to conventional surgeries, such as open surgery, in terms of oncological outcomes, post-operative functionality and quality of life. In Japan, TORS is expected to spread across the country, as it has been covered by health insurance since April 2022. This review highlights the procedures of TORS, its unique aspects, its unparalleled advantages as a minimally invasive surgery for treating laryngeal and pharyngeal cancers, and its current status in Japan.
  • 高橋 和也, 伊藤 正之, 伊藤 文隆, 林 真也, 加藤 久幸, 楯谷 一郎
    臨床放射線 68(11) 1121-1125 2023年11月10日  
  • 吉岡 哲志, 久田 聖, 浅井 康徳, 堀 龍介, 楯谷 一郎
    日本耳科学会総会・学術講演会抄録集 33回 391-391 2023年11月  
  • 吉岡 哲志, 久田 聖, 浅井 康徳, 堀 龍介, 楯谷 一郎
    日本耳科学会総会・学術講演会抄録集 33回 391-391 2023年11月  
  • 西幹 雅俊, 亀島 真由佳, 九鬼 伴樹, 吉岡 哲志, 楯谷 一郎
    日本鼻科学会会誌 62(3) 501-501 2023年9月  
  • 西幹 雅俊, 亀島 真由佳, 九鬼 伴樹, 吉岡 哲志, 楯谷 一郎
    日本鼻科学会会誌 62(3) 501-501 2023年9月  
  • 加藤 久幸, 九鬼 伴樹, 吉岡 哲志, 堀 龍介, 楯谷 一郎
    耳鼻咽喉科臨床 補冊 (補冊161) 72-72 2023年6月  
  • 九鬼 伴樹, 堀 龍介, 吉岡 哲志, 加藤 久幸, 楯谷 一郎
    耳鼻咽喉科臨床 補冊 (補冊161) 81-81 2023年6月  
  • Kensei Naito, Seiji Horibe, Yosuke Tanabe, Hisayuki Kato, Satoshi Yoshioka, Ichiro Tateya
    Fujita medical journal 9(2) 53-64 2023年5月  
    There are many methods and types of equipment for measuring the nasal airway, but there is no consensus regarding the results of various clinical studies on nasal obstruction. In this review, we discuss the two major methods of objectively assessing the nasal airway: rhinomanometry and acoustic rhinometry. The Japanese standard of rhinomanometry in Japanese adults and children was established by the Japanese Standardization Committee on Rhinomanometry in 2001 and 2018, respectively. However, the International Standardization Committee has proposed different standards because of differences in race, equipment, and social health insurance systems. The standardization of acoustic rhinometry in Japanese adults is making progress in several Japanese institutes, but the international standardization of acoustic rhinometry has not yet begun. Rhinomanometry is the physiological expression of nasal airway breathing, whereas acoustic rhinometry is the anatomic expression. In this review, we introduce the history and methods of the objective assessment of nasal patency and the physiological and pathological issues regarding nasal obstruction.
  • Keisuke Mizuno, Yo Kishimoto, Yoshitaka Kawai, Shintaro Fujimura, Ken Iwanaga, Kayoko Mizuno, Takahiro Shimizu, Akira Yokoyama, Mitsuhiro Nikaido, Kenshiro Hirohashi, Manabu Muto, Hiroshi Seno, Ichiro Tateya, Koichi Omori
    International journal of clinical oncology 28(4) 521-530 2023年4月  
    BACKGROUND: Endoscopic laryngopharyngeal surgery (ELPS) is a minimally invasive transoral surgery for superficial pharyngeal and laryngeal cancer, but dysphagia occasionally occurs post-treatment. We investigated dysphagia following ELPS and its risk factors. METHODS: Of the 145 patients who underwent ELPS, 92 were evaluated in this study using the Hyodo score, Functional Outcome Swallowing Scale, Eating Assessment Tool-10 along with the total scores for the three items of the method of intake, time, and food preoperatively and on postoperative 1, 3, and 6 months. We examined the 6-month trends of these values. Furthermore, the fasting period post-surgery, the need for swallowing rehabilitation by a speech therapist, and postoperative pneumonia episodes were set as outcomes reflecting the short-term swallowing function. We determined the associations between these outcomes and patient background factors. RESULTS: Postoperatively, the Hyodo score worsened at 1 month but recovered at 3 months. The Hyodo scores of all patients who underwent postcricoid ELPS did not worsen. The diameter of the resected specimen (DRS) was significantly associated with the need for swallowing rehabilitation and postoperative fasting time. A DRS ≥ 35 mm was considered the threshold for the need of swallowing rehabilitation, postoperative pneumonia, and prolonged postoperative fasting time. CONCLUSION: ELPS exerts a temporal and limited impact on the swallowing function, which recovers within 3 months in every swallowing evaluation. This necessitates additional care during the treatment of patients with mucosal defects ≥ 35 mm, owing to the significant association between the DRS and short-term swallowing function.
  • 大島 夕佳, 池田 裕隆, 田中 優美, 藤澤 怜奈, 高橋 和也, 大野 良治, 外山 宏, 田原 葵, 古田 みなみ, 藤井 直子, 村山 和宏, 吉岡 哲志, 楯谷 一郎
    Japanese Journal of Radiology 41(Suppl.) 24-24 2023年2月  
  • Yoshitaka Kawai, Masanobu Mizuta, Ichiro Tateya, Yo Kishimoto, Shintaro Fujimura, Atsushi Suehiro, Nao Hiwatashi, Koichi Omori
    Auris, nasus, larynx 50(1) 94-101 2023年2月  
    OBJECTIVES: Intraoperative cone beam computed tomography (CBCT) imaging has the potential to facilitate the surgical procedure. The current preliminary retrospective chart review investigated the benefits of intraoperative CBCT during laryngoplasty. METHOD: This study examined 26 cases that underwent intraoperative CBCT imaging during laryngoplasty, with one patient who counted twice due to first and revision surgery. The visual quality of structures of interest (glottal shape, thyroid cartilage, arytenoid cartilage, and implants) was determined using intraoperative CBCT during laryngoplasty. Each patient also underwent an aerodynamic assessment. RESULTS: CBCT provided unique information, such as surgical landmarks in severe scarring, the subglottal shape, and the rotation angle of the arytenoid cartilage during arytenoid adduction. Nonetheless, 26.9% (7 of 26) of cases were affected by motion artifact, due to the long acquisition time. When motion artifact-negative cases were evaluated, 100% of glottal shape and more than 89% of thyroid cartilage were well visualized. All arytenoids were well-visualized in patients ≥ 50 years of age and without motion artifact, while CBCT failed to visualize the arytenoids in 2 of 4 patients who were < 50 years, due to the lack of calcifications. After medialization surgery, the yields of improved maximal phonation times (MPTs) in the motion artifact-negative and -positive groups were 8.7 sec and 3.4 sec, respectively (p = 0.032; Welch's t test). This comparison indicates intraoperative CBCT would contribute in MPT improvement, if CBCT is taken in measurable quality. CONCLUSION: The potential benefits of intraoperative CBCT during laryngoplasty were demonstrated. A corollary, prospective study is warranted to further confirmation.
  • Yu Yamamoto, Masakazu Okawa, Keita Suzuki, Ichiro Tateya, Michio Yoshimura, Yasutaka Fushimi, Eri Toda Kato, Kazumichi Yoshida, Susumu Miyamoto
    Cerebrovascular diseases (Basel, Switzerland) 1-9 2023年1月30日  
    INTRODUCTION: Radiation-induced carotid artery stenosis (RI-CS) is known as one of long-term side effects of radiotherapy for head and neck cancer (HNC). However, the clinical time course after irradiation has been poorly understood. We aimed to investigate the natural history of radiation-induced carotid atherosclerosis, comparing the patients who received radiotherapy for HNC with the patients who were treated without radiotherapy. METHODS: The patients who received treatment of HNC at Department of Otolaryngology, Head and Neck Surgery of Kyoto University Hospital, from November 2012 to July 2015 were enrolled. The patients were assigned into the RT group and the control group, depending on whether radiotherapy was planned or not. Annual carotid ultrasound was performed from the enrollment to 5 years. The increase of mean intima-media thickness (IMT) at common carotid artery from the enrollment (Δmean IMT) was evaluated. RESULTS: Fifty-six patients in the RT group and 25 patients in the control group were enrolled. From 5-year follow-up data, the significant higher increase of Δmean IMT was consistently observed in the RT group than in the control group after 2 years. The RT group presented a 7.8-fold increase of mean IMT compared to the control group (0.060 mm per year in the RT group and 0.008 mm per year in the control group). Cumulative incidence curves obtained from the analysis of all vessels revealed that the RT group presented higher incidence of Δmean IMT ≥0.25 mm than the control group (p < 0.01). In the RT group, the patients with mean IMT ≥1.0 mm at enrollment exhibited significantly higher incidence of Δmean IMT ≥0.25 mm than the patients with mean IMT <1.0 mm (p < 0.01). DISCUSSION: Radiotherapy for HNC induces continuous carotid mean IMT progression. The irradiated carotid arteries with mean IMT ≥1.0 mm before radiotherapy presented earlier IMT progression than those with mean IMT <1.0 mm.
  • 堀 龍介, 吉岡 哲志, 岡上 雄介, 児嶋 剛, 楯谷 一郎
    日本内視鏡外科学会雑誌 27(7) 979-979 2022年12月  
  • 久田 聖, 浅井 康徳, 堀 龍介, 吉岡 哲志, 楯谷 一郎
    日本耳科学会総会・学術講演会抄録集 32回 157-157 2022年10月  
  • 浅井 康徳, 堀 龍介, 吉岡 哲志, 角南 貴司子, 楯谷 一郎
    日本耳科学会総会・学術講演会抄録集 32回 370-370 2022年10月  
  • 亀島 真由佳, 九鬼 伴樹, 岩元 翔吾, 吉岡 哲志, 堀 龍介, 加藤 久幸, 楯谷 一郎, 堀部 晴司
    日本鼻科学会会誌 61(3) 455-455 2022年10月  
  • Tetsuji Sanuki, Nobuhiko Oridate, Ichiro Tateya, Takaharu Nito, Kenji Mizoguchi, Kenichiro Tanabe
    Laryngoscope investigative otolaryngology 7(5) 1481-1490 2022年10月  
    OBJECTIVES: The success of type 2 thyroplasty (TP2) for adductor spasmodic dysphonia (AdSD) depends on the selection of optimally sized titanium bridges, which requires accurate assessment of intraoperative vocal changes. While this procedure has traditionally been performed according to the laryngologist's experience, the most appropriate method for voice monitoring and selection of titanium bridge size remains to be determined. This study aimed to investigate evaluation parameters useful for voice monitoring, as these may allow less experienced surgeons to perform TP2 properly. METHODS: In this prospective study, voice monitoring was performed in 18 patients with AdSD patients undergoing TP2. Evaluations were performed preoperatively, intraoperatively, 13 weeks postoperatively, and 52 weeks postoperatively using GRBAS (grade, roughness, breathiness, asthenia, and strain), as well as perceptual judgment and acoustic analyses. RESULTS: Preoperative and intraoperative assessments of the G, R, B, and S parameters, perceptual judgment, and harmonic-to-noise ratio (HNR) were in moderate or better agreement. Intraoperative and 13- or 52-week postoperative measurements of the R, B, and G parameters and strangulation, tremor, and HNR were also in high agreement. When two different sizes of titanium bridges were compared (unselected vs. selected), ratings for G, R, S, strangulation, tremor, jitter, shimmer, HNR, standard deviation of F0, and degree of voice breaks were better for the selected width than the unselected width. CONCLUSION: The candidate items for intraoperative voice monitoring during TP2 for AdSD are G, R, strangulation, tremor, and HNR. The use of these items may help to ensure successful TP2 and contribute to the advancement of laryngeal framework surgery. LEVEL OF EVIDENCE: Level 4.
  • Daijiro Kojima, Shigeo Ohba, Masato Abe, Atsushi Suzuki, Seiji Horibe, Ichiro Tateya, Mitsuhiro Hasegawa, Yuichi Hirose
    Neuropathology : official journal of the Japanese Society of Neuropathology 42(5) 453-458 2022年7月26日  
    Most osteomalacia-inducing tumors (OITs) are phosphaturic mesenchymal tumors (PMTs) that secrete fibroblast growth factor 23 (FGF23). These tumors usually occur in the bone and soft tissues, and intracranial OITs are rare. Therefore, intracranial OIT is difficult to diagnose and treat. This paper presents a case of intracranial OIT and shows a review of previous cases. A 45-year-old man underwent nasal cavity biopsy and treatment with active vitamin D3 and neutral phosphate for hypophosphatemia. Amplification of FGF23 mRNA level within the tumor was detected. Subsequently, the surgical specimen was diagnosed with a PMT and was considered the cause of the patient's osteomalacia. The patient was referred to a neurosurgery department for the excision of the intracranial tumor extending to the nasal cavity. After tumor removal, the serum levels of FGF23 and phosphorus were normalized as compared to preoperative those. The patient remains disease-free, without additional treatment, approximately 10 years after surgery, with no tumor recurrence. As per the literature, intracranial OITs usually occur in patients aged 8-69 years. Bone and muscle pain are major complaints. Approximately 60% of the patients reported previously had symptoms because of intracranial tumors. In some cases, it took several years to diagnose OIT after the onset of the osteomalacia symptoms. Laboratory data in such cases show hypophosphatemia and elevated FGF23 levels. Because FGF23 levels are associated with the severity of osteomalacia symptoms, total tumor resection is recommended. PMT and hemangiopericytoma (HPC) are histologically similar, but on immunochemistry, PMT is negative for signal transducer and activator of transcription 6 (STAT6), whereas HPC is positive. FGF23 amplification is seen in PMTs but not in HPCs. Therefore, the analysis of FGF23 and STAT6 was helpful in distinguishing PMTs from HPCs. In cases of hypophosphatemia and osteomalacia without a history of metabolic, renal, or malabsorptive diseases, the possibility of oncogenic osteomalacia should be considered.
  • 田邉 陽介, 加藤 久幸, 吉岡 哲志, 岩田 義弘, 楯谷 一郎
    小児耳鼻咽喉科 43(2) 178-178 2022年6月  
  • 九鬼 伴樹, 吉岡 哲志, 戸松 瑛介, 鈴木 敦詞, 楯谷 一郎
    耳鼻咽喉科臨床 115(6) 491-496 2022年6月  
    38歳男性。全身の骨痛、歩行・起立障害を主訴に前医を受診した。腫瘍性骨軟化症(TIO)が疑われ、精査加療目的に当院へ紹介となった。FGF23の全身静脈サンプリングと68Ga-DOTATOC-PET/CTにより右鼻腔内の腫瘤がTIOの原因腫瘍であると診断し、内視鏡下に右鼻腔腫瘍摘出術が施行された。その結果、病理組織学的に鼻腔原発リン酸塩尿性間葉系腫瘍と診断され、術後5日で全身の骨痛は完全消失し、立位保持・歩行ともに可能となった。術後1年経過現在、腫瘍の再発や骨痛の再燃はなく、FGF23も正常範囲内である。
  • 倉田 耀介, 浅井 康徳, 岩元 翔吾, 森 茂彰, 日江井 裕介, 田邉 陽介, 岩田 義弘, 吉岡 哲志, 堀 龍介, 加藤 久幸, 楯谷 一郎
    頭頸部癌 48(2) 237-237 2022年5月  
  • 佐野 大佑, 清水 顕, 楯谷 一郎, 藤原 和典, 岸本 曜, 丸尾 貴志, 藤本 保志, 塚原 清彰, 森 照茂, 加藤 久幸, 折舘 伸彦
    日本気管食道科学会会報 73(2) 98-101 2022年4月  
  • 岩元 翔吾, 浅井 康徳, 森 茂彰, 田邊 陽介, 日江井 祐介, 吉岡 哲志, 堀 龍介, 加藤 久幸, 楯谷 一郎
    日本耳鼻咽喉科頭頸部外科学会会報 125(4) 795-795 2022年4月  
  • 岩元 翔吾, 吉岡 哲志, 岩田 義弘, 加藤 久幸, 楯谷 一郎
    日本気管食道科学会会報 73(2) s79-s79 2022年4月  
  • Kanako Kondo, Masanobu Mizuta, Yoshitaka Kawai, Tohru Sogami, Shintaro Fujimura, Tsuyoshi Kojima, Chika Abe, Ryo Tanaka, Osamu Shiromoto, Ryuji Uozumi, Yo Kishimoto, Ichiro Tateya, Koichi Omori, Tomoyuki Haji
    Journal of speech, language, and hearing research : JSLHR 64(12) 4754-4761 2021年12月13日  
    PURPOSE: Auditory-perceptual evaluation is essential for the assessment of voice quality. The Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V) provides a standardized protocol and assessment form for clinicians to analyze the voice quality and has been adapted into several different languages. The aims of this study were to develop the Japanese version of the CAPE-V and to investigate its reliability and validity. METHOD: The Japanese CAPE-V consisted of the same three speech contexts (vowels, sentences, and conversation) as developed in the original English version. The sentences were designed according to the concepts of the original version and reviewed by Japanese phoneticians. To validate the usefulness of the Japanese CAPE-V, voices of 173 Japanese-speaking subjects (76 subjects with dysphonia and 97 without voice complaints) were evaluated by five experienced judges, according to the Japanese CAPE-V as well as the GRBAS (Grade, Roughness, Breathiness, Asthenia, Strain) scale. RESULTS: The Japanese CAPE-V provided a high interrater reliability (intraclass correlation coefficients [ICCs] > .85 for all the parameters) as well as a high intrarater reliability (ICCs > .85 for all the parameters). In addition, overall severity, roughness, and breathiness in the Japanese CAPE-V were highly correlated with the corresponding dimensions in the GRBAS scale, having Spearman correlation coefficients greater than .8. CONCLUSION: This study demonstrated the reliability and validity of the newly developed Japanese CAPE-V as an auditory-perceptual evaluation instrument.
  • 堀 龍介, 児嶋 剛, 浅井 康徳, 吉岡 哲志, 楯谷 一郎
    日本耳科学会総会・学術講演会抄録集 31回 235-235 2021年10月  
  • 吉岡 哲志, 浅井 康徳, 堀 龍介, 楯谷 一郎
    日本耳科学会総会・学術講演会抄録集 31回 411-411 2021年10月  
  • 金沢 佑治, 岸本 曜, 讃岐 徹治, 廣芝 新也, 大森 孝一, 楯谷 一郎
    音声言語医学 62(4) 287-293 2021年10月  
  • 堀 龍介, 児嶋 剛, 浅井 康徳, 吉岡 哲志, 楯谷 一郎
    日本耳科学会総会・学術講演会抄録集 31回 235-235 2021年10月  
  • 犬塚 雄貴, 田邉 陽介, 岩田 義弘, 加藤 久幸, 楯谷 一郎
    耳鼻咽喉科臨床 補冊 (補冊157) 104-104 2021年6月  
  • Taizo Yokokawa, Yosuke Ariizumi, Mariko Hiramatsu, Yujin Kato, Kazuhira Endo, Kazufumi Obata, Kayoko Kawashima, Toshifumi Sakata, Shigeru Hirano, Torahiko Nakashima, Tatsurou Sekine, Asanori Kiyuna, Saeko Uemura, Keisuke Okubo, Taro Sugimoto, Ichiro Tateya, Yasushi Fujimoto, Arata Horii, Yurika Kimura, Masamitsu Hyodo, Akihiro Homma
    Auris Nasus Larynx 48(3) 525-529 2021年6月  
  • Daisuke Sano, Akira Shimizu, Ichiro Tateya, Kazunori Fujiwara, Terushige Mori, Shunsuke Miyamoto, Daisuke Nishikawa, Tomonori Terada, Ryuji Yasumatsu, Tsutomu Ueda, Fumihiko Matsumoto, Yo Kishimoto, Takashi Maruo, Yasushi Fujimoto, Kiyoaki Tsukahara, Seiichi Yoshimoto, Ken ichi Nibu, Nobuhiko Oridate
    Auris Nasus Larynx 48(3) 502-510 2021年6月  
  • Satsuki Asai, Shinji Sumiyoshi, Yosuke Yamada, Ichiro Tateya, Toshitaka Nagao, Sachiko Minamiguchi, Hironori Haga
    Pathology International 71(6) 427-434 2021年6月  
  • Chikatoshi Katada, Manabu Muto, Satoshi Fujii, Tetsuji Yokoyama, Tomonori Yano, Akihito Watanabe, Toshiro Iizuka, Shigetaka Yoshinaga, Ichiro Tateya, Hiroki Mitani, Yuichi Shimizu, Akiko Takahashi, Tomoyuki Kamijo, Noboru Hanaoka, Makoto Abe, Akihiro Shiotani, Koichi Kano, Yukinori Asada, Tamotsu Matsuhashi, Hirohito Umeno, Kenji Okami, Kenichi Goda, Shinichiro Hori, Yoichiro Ono, Shuji Terai, Yasuaki Nagami, Kenichi Takemura, Kenro Kawada, Mizuo Ando, Naoto Shimeno, Akihito Arai, Yasutoshi Sakamoto, Masaaki Ichinoe, Tetsuo Nemoto, Masahiro Fujita, Hidenobu Watanabe, Tadakazu Shimoda, Atsushi Ochiai, Takakuni Kato, Ryuichi Hayashi
    Cancer Medicine 10(12) 3848-3861 2021年6月  
  • 荒木 幸仁, 吉本 世一, 冨藤 雅之, 松浦 一登, 藤原 和典, 楯谷 一郎, 梅野 博仁, 中溝 宗永, 林 隆一, 丹生 健一, 塩谷 彰浩
    頭頸部癌 47(2) 114-114 2021年5月  
  • 佐野 大佑, 清水 顕, 楯谷 一郎, 藤原 和典, 岸本 曜, 丸尾 貴志, 藤本 保志, 塚原 清彰, 吉本 世一, 丹生 健一, 折舘 伸彦
    頭頸部癌 47(2) 113-113 2021年5月  
  • 森 茂彰, 日江井 裕介, 加藤 久幸, 楯谷 一郎
    頭頸部癌 47(2) 217-217 2021年5月  
  • 九鬼 伴樹, 岩元 翔吾, 吉岡 哲志, 中田 誠一, 楯谷 一郎
    日本耳鼻咽喉科学会会報 124(4) 647-647 2021年4月  
  • 岩元 翔吾, 犬塚 雄貴, 日江井 裕介, 吉岡 哲志, 小林 正佳, 加藤 久幸, 楯谷 一郎
    日本耳鼻咽喉科学会会報 124(4) 626-626 2021年4月  
  • 岩元 翔吾, 犬塚 雄貴, 日江井 裕介, 吉岡 哲志, 小林 正佳, 加藤 久幸, 楯谷 一郎
    日本耳鼻咽喉科学会会報 124(4) 626-626 2021年4月  
  • 九鬼 伴樹, 岩元 翔吾, 吉岡 哲志, 中田 誠一, 楯谷 一郎
    日本耳鼻咽喉科学会会報 124(4) 647-647 2021年4月  

MISC

 142

共同研究・競争的資金等の研究課題

 23